SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DNOW, TASK, YMAB on Behalf of Shareholders
Investigation by Halper Sadeh LLC: The law firm is investigating DNOW Inc., TaskUs, Inc., and Y-mAbs Therapeutics, Inc. for potential violations of federal securities laws and breaches of fiduciary duties to shareholders.
DNOW Inc. Merger: DNOW's merger with MRC Global Inc. will result in DNOW shareholders owning approximately 56.5% of the combined company post-transaction.
TaskUs Sale Details: TaskUs is being sold to affiliates of Blackstone and its executives for $16.50 per share, prompting an investigation into shareholder rights.
Y-mAbs Acquisition: Y-mAbs Therapeutics is set to be sold to SERB Pharmaceuticals for $8.60 per share in cash, with Halper Sadeh LLC seeking increased consideration and additional disclosures for shareholders.
Trade with 70% Backtested Accuracy
Analyst Views on DNOW
About DNOW
About the author

- Securities Claims Investigation: The Rosen Law Firm is investigating potential securities claims on behalf of DNOW Inc. (NYSE: DNOW) shareholders due to allegations of misleading business information, aiming to protect investor rights and seek compensation.
- Stock Price Impact: On February 20, 2026, DNOW's stock plummeted by 19.1% after the company reported disappointing Q4 2025 financial results, which missed Wall Street expectations, exacerbating investor losses.
- Class Action Preparation: The Rosen Law Firm is preparing a class action lawsuit, allowing investors to participate without any out-of-pocket costs, demonstrating a commitment to recovering losses for affected investors.
- Firm's Reputation: Known for its success in securities class actions, the Rosen Law Firm recovered over $438 million for investors in 2019 alone, highlighting its leadership and expertise in the industry.
- Securities Fraud Investigation: The Rosen Law Firm is investigating potential securities claims against DNOW Inc. (NYSE:DNOW) for allegedly issuing materially misleading business information, indicating a risk of improper disclosures that could undermine investor confidence.
- Stock Price Plunge: On February 20, 2026, DNOW's stock fell by 19.1% following the release of disappointing Q4 2025 financial results, which not only reflects severe operational missteps but may also trigger collective lawsuits from investors, increasing the company's legal risks.
- Class Action Preparation: The Rosen Law Firm is preparing a class action against DNOW, allowing investors to seek compensation without any out-of-pocket costs, a move that could attract more affected investors and intensify legal pressure on DNOW.
- Law Firm's Credentials: The Rosen Law Firm is renowned for its successful track record in securities class actions, having recovered over $438 million for investors in 2019 alone, showcasing its expertise and resource advantages in handling similar cases, which could significantly impact the outcome of future litigation against DNOW.
- Securities Claims Investigation: The Rosen Law Firm is investigating potential securities claims against DNOW Inc. (NYSE: DNOW) for allegedly issuing materially misleading business information, indicating significant legal risks for the company.
- Stock Price Impact: On February 20, 2026, DNOW's stock plummeted by 19.1% following the release of disappointing Q4 2025 financial results, reflecting market concerns over the company's financial health and potentially affecting future financing capabilities.
- Class Action Preparation: The Rosen Law Firm is preparing a class action lawsuit against DNOW, allowing investors to participate without any out-of-pocket costs, demonstrating the firm's commitment to protecting investor rights.
- Firm Reputation: The Rosen Law Firm is renowned for its successful track record in securities class actions, having recovered over $438 million for investors in 2019 alone, underscoring its leadership and expertise in the industry.
- Securities Fraud Investigation: The Rosen Law Firm is investigating potential securities claims against DNOW Inc. (NYSE:DNOW) for allegedly issuing materially misleading business information, indicating possible concealment of critical information from investors that led to financial losses.
- Stock Price Impact: On February 20, 2026, DNOW reported disappointing fourth-quarter 2025 results, revealing significant losses that missed Wall Street expectations, resulting in a 19.1% drop in stock price on that day, severely undermining investor confidence.
- Class Action Preparation: The Rosen Law Firm is preparing a class action lawsuit, allowing affected investors to seek compensation without upfront fees, demonstrating the firm's strong commitment to protecting investor rights.
- Firm's Track Record: Known for its success in securities class actions, the Rosen Law Firm recovered over $438 million for investors in 2019 alone, showcasing its extensive experience and resources in handling such cases effectively.
- Complete Exit: On February 17, 2026, Quantedge Capital disclosed in an SEC filing that it fully sold its 351,310 shares of DNOW, valued at $5.36 million, reflecting a cautious stance on the company's future performance.
- Declining AUM Proportion: This sale reduced DNOW's representation in Quantedge's assets under management from 2.9% to 0%, indicating investor concerns over the company's integration challenges and poor market performance.
- Poor Market Performance: As of Monday, DNOW shares were priced at $11.79, down approximately 27% over the past year, significantly underperforming the S&P 500, which rose about 15% in the same period, suggesting a lack of confidence in its recovery prospects.
- Complex Financial Situation: Despite generating $2.8 billion in revenue last year and achieving five consecutive years of revenue growth, DNOW reported a net loss of $89 million, primarily due to costs associated with the MRC Global acquisition, highlighting execution risks during its transition.
- Securities Claims Investigation: The Rosen Law Firm is investigating potential securities claims against DNOW Inc. (NYSE: DNOW) due to allegations of issuing materially misleading business information, indicating possible investor losses.
- Stock Price Plunge: On February 20, 2026, DNOW's stock fell 19.1% after the company reported disappointing fourth-quarter 2025 financial results, which missed Wall Street expectations, exacerbating investor concerns.
- Class Action Preparation: The Rosen Law Firm is preparing a class action to seek compensation for affected investors, with no out-of-pocket fees required, thereby lowering the barrier for participation in the lawsuit.
- Firm's Track Record: The Rosen Law Firm is renowned for its success in securities class actions, having recovered over $438 million for investors in 2019 alone, showcasing its expertise and experience in handling such cases.











